RTI Surgical (NASDAQ:RTIX) was downgraded by equities research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued on Thursday.
Separately, Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, October 13th.
Shares of RTI Surgical (NASDAQ RTIX) opened at $4.20 on Thursday. RTI Surgical has a one year low of $3.01 and a one year high of $6.00. The company has a quick ratio of 1.21, a current ratio of 3.34 and a debt-to-equity ratio of 0.25. The stock has a market cap of $249.94, a price-to-earnings ratio of 107.50, a PEG ratio of 5.73 and a beta of 1.76.
Several large investors have recently modified their holdings of RTIX. Cigna Investments Inc. New purchased a new position in shares of RTI Surgical in the 2nd quarter worth about $105,000. Prudential Financial Inc. purchased a new position in shares of RTI Surgical in the 3rd quarter worth about $111,000. Citadel Advisors LLC lifted its holdings in RTI Surgical by 85.7% during the third quarter. Citadel Advisors LLC now owns 26,786 shares of the medical equipment provider’s stock valued at $122,000 after purchasing an additional 12,361 shares during the last quarter. Citigroup Inc. lifted its holdings in RTI Surgical by 2,850.1% during the second quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock valued at $124,000 after purchasing an additional 20,435 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC purchased a new stake in RTI Surgical during the third quarter valued at about $144,000. 69.92% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION NOTICE: This report was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this report on another site, it was copied illegally and republished in violation of United States and international copyright legislation. The legal version of this report can be viewed at https://stocknewstimes.com/2017/12/16/rti-surgical-rtix-stock-rating-lowered-by-bidaskclub.html.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.